AXP vs DARE · P/E 20, rev $21.73B vs rev $187.5K
American Express Company (AXP) versus Dare Bioscience Inc (DARE) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported DARE revenue for 2026-06-30 was $187.5K. Net income was -$3.0M. Revenue was up 23.0% from 2026-03-31 to 2026-06-30. DARE currently screens at market cap $21.2M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. DARE currently screens at market cap $21.2M.
Not investment advice. Open the AXP and DARE stock pages for the full models.
Not investment advice.